GB9605945D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: GB9605945D0
Authority: GB; United Kingdom
Prior art keywords: novel compounds; novel; compounds
Prior art date: 1996-03-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GBGB9605945.6A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Original Assignee

SmithKline Beecham Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-21

Filing date

1996-03-21

Publication date

1996-05-22

1996-03-21 Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd

1996-03-21 Priority to GBGB9605945.6A priority Critical patent/GB9605945D0/en

1996-05-22 Publication of GB9605945D0 publication Critical patent/GB9605945D0/en

1997-03-19 Priority to PCT/EP1997/001405 priority patent/WO1997034900A1/en

1997-03-19 Priority to JP9533158A priority patent/JP2000506877A/en

1997-03-19 Priority to EP97914272A priority patent/EP0888357A1/en

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

GBGB9605945.6A 1996-03-21 1996-03-21 Novel compounds Pending GB9605945D0 (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
GBGB9605945.6A GB9605945D0 (en)	1996-03-21	1996-03-21	Novel compounds
PCT/EP1997/001405 WO1997034900A1 (en)	1996-03-21	1997-03-19	Azaspiro derivatives
JP9533158A JP2000506877A (en)	1996-03-21	1997-03-19	Azaspiro derivative
EP97914272A EP0888357A1 (en)	1996-03-21	1997-03-19	Azaspiro derivatives

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9605945.6A GB9605945D0 (en)	1996-03-21	1996-03-21	Novel compounds

Publications (1)

Publication Number	Publication Date
GB9605945D0 true GB9605945D0 (en)	1996-05-22

Family

ID=10790780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9605945.6A Pending GB9605945D0 (en)	1996-03-21	1996-03-21	Novel compounds

Country Status (4)

Country	Link
EP (1)	EP0888357A1 (en)
JP (1)	JP2000506877A (en)
GB (1)	GB9605945D0 (en)
WO (1)	WO1997034900A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7279576B2 (en)	2002-12-31	2007-10-09	Deciphera Pharmaceuticals, Llc	Anti-cancer medicaments
US7144911B2 (en)	2002-12-31	2006-12-05	Deciphera Pharmaceuticals Llc	Anti-inflammatory medicaments
US7202257B2 (en)	2003-12-24	2007-04-10	Deciphera Pharmaceuticals, Llc	Anti-inflammatory medicaments
EP2146717A4 (en)	2007-04-20	2010-08-11	Deciphera Pharmaceuticals Llc	Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
US7858666B2 (en)	2007-06-08	2010-12-28	Mannkind Corporation	IRE-1α inhibitors
US8461179B1 (en)	2012-06-07	2013-06-11	Deciphera Pharmaceuticals, Llc	Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
MX2022001863A (en)	2019-08-12	2022-05-30	Deciphera Pharmaceuticals Llc	Ripretinib for treating gastrointestinal stromal tumors.
TW202122082A (en)	2019-08-12	2021-06-16	美商迪賽孚爾製藥有限公司	Methods of treating gastrointestinal stromal tumors
LT4084778T (en)	2019-12-30	2024-01-25	Deciphera Pharmaceuticals, Llc	Amorphous kinase inhibitor formulations and methods of use thereof
IL293864A (en)	2019-12-30	2022-08-01	Deciphera Pharmaceuticals Llc	Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
US11779572B1 (en)	2022-09-02	2023-10-10	Deciphera Pharmaceuticals, Llc	Methods of treating gastrointestinal stromal tumors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE204262T1 (en) *	1991-09-18	2001-09-15	Glaxo Group Ltd	BENZANILIDE DERIVATIVES AS 5-HT1D ANTAGONISTS
GB9326008D0 (en) *	1993-12-21	1994-02-23	Smithkline Beecham Plc	Novel compounds
GB9421003D0 (en) *	1994-10-18	1994-12-07	Smithkline Beecham Plc	Novel compounds

1996
- 1996-03-21 GB GBGB9605945.6A patent/GB9605945D0/en active Pending
1997
- 1997-03-19 EP EP97914272A patent/EP0888357A1/en not_active Withdrawn
- 1997-03-19 WO PCT/EP1997/001405 patent/WO1997034900A1/en not_active Application Discontinuation
- 1997-03-19 JP JP9533158A patent/JP2000506877A/en active Pending

Also Published As

Publication number	Publication date
JP2000506877A (en)	2000-06-06
EP0888357A1 (en)	1999-01-07
WO1997034900A1 (en)	1997-09-25

Publication	Publication Date	Title
EP0914330A4 (en)	2002-01-09	Novel compounds
EP0961618A4 (en)	2002-07-17	Novel compounds
EP0904104A4 (en)	1999-11-03	Novel compounds
GB9601067D0 (en)	1996-03-20	Novel compounds
EP0904105A4 (en)	1999-10-20	Novel compounds
AP9701047A0 (en)	1997-07-31	Novel compounds
GB9605945D0 (en)	1996-05-22	Novel compounds
AP9701037A0 (en)	1997-07-31	Novel compounds
GB9601041D0 (en)	1996-03-20	Novel compounds
GB9604045D0 (en)	1996-04-24	Novel compounds
GB9605381D0 (en)	1996-05-15	Novel compounds
GB9605883D0 (en)	1996-05-22	Novel compounds
EP0954525A4 (en)	2001-09-12	Novel compounds
GB9601068D0 (en)	1996-03-20	Novel compounds
GB9606208D0 (en)	1996-05-29	Novel compounds
GB9601099D0 (en)	1996-03-20	Novel compounds
GB9601066D0 (en)	1996-03-20	Novel compounds
GB9615230D0 (en)	1996-09-04	Novel compounds
GB9605153D0 (en)	1996-05-15	Novel compounds
GB9601096D0 (en)	1996-03-20	Novel compounds
GB9603655D0 (en)	1996-04-17	Novel compounds
GB9608852D0 (en)	1996-07-03	Novel compounds
GB9603654D0 (en)	1996-04-17	Novel compounds
GB9601235D0 (en)	1996-03-20	Novel compounds
GB9606199D0 (en)	1996-05-29	Novel compounds